) In a variety of organisms, mutations that cause depletion of DNA replication enzymes increase the incidence of genetic instability-- events that are characterized by elevated rates of recombination deletion, and/or chromosome loss. Many of the cellular phenotypes of Werner Syndrome (WS) suggest that it falls into this class of genetic defect. The Werner syndrome gene WRN was recently cloned and sequenced and was found to encode a DNA helicase of the RecQ family. The applicants propose that cells that carry out replication in the absence of the WRN helicase leave behind lesions in the DNA that are repaired by a recombination system that produces the genomic rearrangements. They plan to explore this possibility in yeast, by looking for specific types of replication defects that might be generated in the absence of the yeast WRN helicase homologue, Sgs1p. In addition, by studying the types of recombination events induced in yeast cells deficient for the Sgs1 protein, and by looking for proteins that interact with both the normal WRN and Sgs1 helicases, they hope to gain insight into the types of primary damage generated by the replication machinery in the absence of this helicase. The identification of yeast proteins with homology to human proteins and the ability to study them genetically in yeast has led to an understanding of many processes that contribute to human disease. Because of the small genome size of S. cerevisiae-- recently sequenced in its entirety-- the physical analysis of chromosomes during their replication is quite feasible. In no other eukaryotic organism have the cis-acting elements and trans-acting proteins for replication initiation been as well characterized as they have been in yeast. Moreover, the ease with which the genome can be manipulated makes yeast an ideal host organism in which to study basic chromosome biology. Finally, yeast provides a user-friendly cellular environment in which to study protein-protein interactions by way of the two-hybrid transcriptional reporter system.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA077852-01A1
Application #
6167457
Study Section
Project Start
1999-05-14
Project End
2000-02-29
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Orozco, Javier I J; Knijnenburg, Theo A; Manughian-Peter, Ayla O et al. (2018) Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat Commun 9:4627
Schmitt, Michael W; Pritchard, Justin R; Leighow, Scott M et al. (2018) Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias. Clin Cancer Res 24:5321-5334
Mikheev, Andrei M; Mikheeva, Svetlana A; Severs, Liza J et al. (2018) Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma. Mol Oncol 12:1188-1202
Lee, Su-In; Celik, Safiye; Logsdon, Benjamin A et al. (2018) A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat Commun 9:42
Salk, Jesse J; Schmitt, Michael W; Loeb, Lawrence A (2018) Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations. Nat Rev Genet 19:269-285
Davis, Luther; Zhang, Yinbo; Maizels, Nancy (2018) Assaying Repair at DNA Nicks. Methods Enzymol 601:71-89
Yu, Ming; Heinzerling, Tai J; Grady, William M (2018) DNA Methylation Analysis Using Droplet Digital PCR. Methods Mol Biol 1768:363-383
Knijnenburg, Theo A; Wang, Linghua; Zimmermann, Michael T et al. (2018) Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23:239-254.e6
Poston, Jacqueline N; Becker, Pamela S (2017) Controversies Regarding Use of Myeloid Growth Factors in Leukemia. J Natl Compr Canc Netw 15:1551-1557
Kamath-Loeb, Ashwini S; Zavala-van Rankin, Diego G; Flores-Morales, Jeny et al. (2017) Homozygosity for the WRN Helicase-Inactivating Variant, R834C, does not confer a Werner syndrome clinical phenotype. Sci Rep 7:44081

Showing the most recent 10 out of 137 publications